Fig. 5.

Prediction of chemotherapeutic response for GC stem cell subtypes. Sensitivity of a camptothecin, b methotrexate, c mitomycin C, d doxorubicin, e gemcitabine, f paclitaxel, m imatinib, n bleomycin, o docetaxel, p sunitinib, q vinblastine, and r cisplatin in SCE_L and SCE_H in the TCGA cohort. Sensitivity of g camptothecin, h methotrexate, i mitomycin C, j doxorubicin, k gemcitabine, l paclitaxel, s imatinib, t blemycin, u docetaxel, v sunitinib, w vinblastine, and x cisplatin in SCE_L and SCE_H in the GSE84437 dataset